Back to search

Boston University

Ketamine: a feasible replacement for current major depressive disorder therapies

Abstract

dc:description.abstract

Major depressive disorder (MDD) is among the most common mental health problems in the U.S. and the world. A significant portion of patients with MDD do not respond to current antidepressant medications and are considered treatment-resistant. Current antidepressant therapies have a late onset of action that causes significant challenges when treating patients with suicidal ideation. In the past two decades, there has been significant interest in the anesthetic drug ketamine as an antidepressant. Evidence suggests that ketamine is effective even in treatment-resistant patients, with rapid onset of benefits observed hours after administration. The U.S. Food and Drug Administration has recently approved a nasal spray containing the S-enantiomer of ketamine, or esketamine, as an antidepressant therapy. This thesis reviewed the literature on both ketamine and esketamine as antidepressants, with a focus on the two most commonly used routes of administration, intravenous infusion and intranasal administration. This study concludes that both ketamine and esketamine have robust and rapid antidepressant effects. Both formulations are safe and well tolerated by patients, with transient, nonserious side effects easily managed and monitored by healthcare providers. Further research should focus on broadening the availability of ketamine and esketamine to patients.

Degree

thesis:*
Name thesis:degree_name
Master of Science
Level thesis:degree_level
masters
Discipline thesis:degree_discipline
Medical Sciences
Grantor
Boston University
Year dc:date.issued
2021

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Derman, Ege
Advisors dc:contributor.advisor
  • Spencer, Jean L.
  • Offner, Gwynneth D.

Subjects

dc:subject × 4

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/43339

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Derman, Ege. Ketamine: a feasible replacement for current major depressive disorder therapies. masters thesis, Boston University, 2021. https://hdl.handle.net/2144/43339